Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
1.030
+0.020 (1.98%)
Oct 19, 2026, 3:12 PM EDT - Market open
Stereotaxis Market Cap
Stereotaxis has a market cap or net worth of $103.21 million as of October 19, 2026. It is the 25,173rd most valuable company in the world and the 4,087th biggest in the United States. Its market cap has decreased by 61.93% in one year.
Market Cap
103.21M
Enterprise Value
97.89M
1-Year Change
-61.93%
Global Rank
Country Rank
#4,087 United States
Category
ChartMarket Cap Chart
Since August 12, 2004, Stereotaxis's market cap has decreased from $183.10M to $103.21M, a decrease of -43.63%. That is a compound annual growth rate of -2.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 103.21M | -51.91% |
| Dec 31, 2025 | 214.60M | 11.08% |
| Dec 31, 2024 | 193.20M | 36.54% |
| Dec 29, 2023 | 141.50M | -8.65% |
| Dec 30, 2022 | 154.90M | -66.50% |
| Dec 31, 2021 | 462.40M | 23.27% |
| Dec 31, 2020 | 375.10M | 6.26% |
| Dec 31, 2019 | 353.00M | 474.92% |
| Dec 31, 2018 | 61.40M | 237.36% |
| Dec 29, 2017 | 18.20M | 28.17% |
| Dec 30, 2016 | 14.20M | -10.69% |
| Dec 31, 2015 | 15.90M | -47.52% |
| Dec 31, 2014 | 30.30M | -47.49% |
| Dec 31, 2013 | 57.70M | 215.30% |
| Dec 31, 2012 | 18.30M | -55.90% |
| Dec 30, 2011 | 41.50M | -76.45% |
| Dec 31, 2010 | 176.20M | -2.22% |
| Dec 31, 2009 | 180.20M | 19.97% |
| Dec 31, 2008 | 150.20M | -63.64% |
| Dec 31, 2007 | 413.10M | 27.11% |
| Dec 29, 2006 | 325.00M | 49.56% |
| Dec 30, 2005 | 217.30M | 991.96% |
| Dec 31, 2004 | 19.90M | -89.13% |
| Aug 12, 2004 | 183.10M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanara MedTech | 304.68M |
| OraSure Technologies | 248.98M |
| Utah Medical Products | 237.23M |
| Pro-Dex | 186.63M |
| Jin Medical International | 163.15M |
| KORU Medical Systems | 138.52M |
| Anbio Biotechnology | 137.38M |
| Daxor | 58.67M |